Close

Agenus (AGEN) Reports Biologics License Application Submission to FDA for Patients with Recurrent or Metastatic Cervical Cancer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/24/2024

1. TSLA
2. ENPH
3. TXN
4. SPOT
5. V
6. KMB
7. FI
8. BA
9. PNR
10. MSCI


Go back to Agenus (AGEN) Reports Biologics License Application Submission to FDA for Patients with Recurrent or Metastatic Cervical Cancer
AGENUS (NASDAQ: AGEN) Delayed: 6.46 --0 (-0%)
Previous Close $6.46    52 Week High $7.49 
Open $6.46    52 Week Low $2.61 
Day High $6.46    P/E N/A 
Day Low $6.46    EPS $-1.10 
Volume 3,745